Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 4/20 | 0.78 |
| ▸ | AGTR2 | P50052 | 4/20 | 0.78 |
| ▸ | PPARG | P37231 | 6/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.62 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.62 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764119 | 0.99 | AGTR1 (0.76) | AGTR1AGTR2PPARGLMNAMEN1 | |
| SCHEMBL7545514 | 0.99 | AGTR1 (0.76) | AGTR1AGTR2PPARGLMNAMEN1 | |
| SCHEMBL7545509 | 0.99 | AGTR1 (0.76) | AGTR1AGTR2PPARGLMNAMEN1 | |
| SCHEMBL29411886 | 0.99 | AGTR1 (0.76) | AGTR1AGTR2PPARGLMNAMEN1 | |
| SCHEMBL28487275 | 0.99 | AGTR1 (0.76) | AGTR1AGTR2PPARGLMNAMEN1 | |
| SCHEMBL13261296 | 0.91 | AGTR1 (0.73) | AGTR1AGTR2PPARGLMNAPDE4D | |
| SCHEMBL13508734 | 0.89 | AGTR1 (0.71) | AGTR1AGTR2PPARGLMNAPDE4D | |
| SCHEMBL9197881 | 0.88 | AGTR1 (1.00) | AGTR1AGTR2PPARG | |
| SCHEMBL29411883 | 0.87 | LMNA (0.81) | AGTR1AGTR2LMNAMEN1KMT2A | |
| SCHEMBL28481747 | 0.87 | LMNA (0.81) | AGTR1AGTR2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130210817-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | SYNGENTA CROP PROTECTION LLC (US) | 2013-08-15 | — | — | US | disclosed |
| EP-2002722-A1 | Methods of controlling insects | Syngeta Participations AG (CH) | 2008-12-17 | — | — | EP | disclosed |
| CN-1045907-A | Improve the insecticides of effect | CIBA GEIGY AG (CH) | 1990-10-10 | — | — | CN | disclosed |
| EP-0210129-B1 | GRAFT POLYMER SOLUBLE OR DISPERSIBLE IN WATER, ITS PREPARATION AND USE | CIBA-GEIGY AG (CH) | 1990-04-18 | — | — | EP | disclosed |
| EP-0210952-B1 | AQUEOUS, ALKALINE, SILICATE-CONTAINING COMPOSITION FOR THE BLEACHING OF CELLULOSIC FIBRES IN THE PRESENCE OF PERCOMPOUNDS | CIBA-GEIGY AG (CH) | 1989-08-23 | — | — | EP | disclosed |
| EP-0293807-A2 | Solid formulation of anionic dyes | CIBA-GEIGY AG (CH) | 1988-12-07 | — | — | EP | disclosed |
| EP-0210952-A1 | Aqueous, alkaline, silicate-containing composition for the bleaching of cellulosic fibres in the presence of percompounds | CIBA-GEIGY AG (CH) | 1987-02-04 | — | — | EP | disclosed |
| EP-0210132-A1 | Aqueous, alkaline, silicate-containing composition for the bleaching of cellulosic fibres in the presence of percompounds | CIBA-GEIGY AG (CH) | 1987-01-28 | — | — | EP | disclosed |
| EP-0098803-A1 | Water-soluble or dispersible graft polymers, their production and use | CIBA-GEIGY AG (CH) | 1984-01-18 | — | — | EP | disclosed |
| US-4105401-A | Dye preparation soluble in cold water | CIBA-GEIGY CORPORATION (US) | 1978-08-08 | — | — | US | disclosed |
| US-4062796-A | CATIONIC SURFACTANT, SODIUM ACRYLATE HOMOPOLYMER | HALLIBURTON COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
| US-3984594-A | Method for producing cellulosic fiber-containing yarns with a non-aqueous sizing solution | KANEBO, LTD. (JA) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210817-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | HCN3, PNN, HCN1 | AGTR1 1279/4885AGTR2 992/4885PPARG 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.